Derived neutrophil lymphocyte ratio may predict bene fi t from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies
暂无分享,去创建一个
Y. Kakeji | K. Tanabe | M. Takeuchi | K. Chìn | W. Ichikawa | C. Kunisaki | M. Fujii | M. Terashima | A. Tsuji | K. Nishikawa | N. Matsuhashi | K. Yoshida | T. Kawase | M. Kochi | A. Takagane | T. Ohno | K. Chin